PHARMACEUTICAL EXECUTIVE NEWSLETTER

In this ISSUE

Europe’s "Radical" Regulators Drawn Further into Pricing Debate

Collaboration to Tackle HIV in Fast-Track Cities

EMA to Review Safety in First-in-Human Clinical Trials

Industry Trends and Spend

Brexit and the UK Pharma Industry

Eleanor Biggs looks at the biggest uncertainties facing the pharma industry if the UK were to leave the EU.
... /Read more/

Watch this brief video to learn how emerging technologies and virtual engagements like teledetailing and telepromotions can help you succeed in the evolving model for prescriber engagement.

Learn more

Opinion

Pharma and Biotech Financial Outlook: Hazy

Do recent trends in the pharma and biotech M&A and equity markets signal a temporary lull — or a permanent drop?
... /Read more/

Calendar

/ Microbiology Week 2016 /

/ 14^th Annual Product Complaints Congress for Life Sciences /

/ Life Sciences’ 12^th Annual Product Recalls Summit /

/ 12^th Annual Commercial Contracts & Chargeback Management /

/ Pharmacy Channel Strategies for Specialty Products /

/ Off-Label Guidelines /

Technology

Snapchat: A Platform for Pharma Marketing?

Is Snapchat just for fun, or should pharma marketers be taking it seriously as a media platform? Peter Houston takes a look.
... /Read more/

Investment

Investing in Patient-Centric Capabilities Requires a Clear Strategy

For those willing to invest in the right capabilities, offering patient services can give pharma companies a tremendous opportunity.
... /Read more/

Opinion

The UK Pay-or-Play Solution: A Horribly Flawed Idea

We desperately need new anti-infective drugs to avoid life threatening infections. Let’s make that happen by punishing companies who don’t invest in R&D for these specific drugs.
... /Read more/

update my profile / advertise with us / print & digital subscribe / visit pharmexec.com